Transcriptomic Analyses Reveal Gene Expression Profiles and Networks in Nasopharyngeal Carcinoma
Authors:
Open Access
- 25 January 2021
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2021 (1)
Abstract
Background. Nasopharyngeal carcinoma (NPC) is a rare but highly aggressive tumor that is predominantly encountered in Southeast Asia and China in particular. Aside from radiotherapy, no effective therapy that specifically treats NPC is available, including targeted drugs. Finding more sensitive biomarkers is important for new drug discovery and for evaluating patient prognosis. Methods. mRNA expression datasets from the Gene Expression Omnibus database (GSE53819, GSE64634, and GSE40290) were selected. After all samples in each dataset were subjected to quality control using principal component analyses, the qualified samples were used for additional analyses. The genes that were significantly expressed in each dataset were intersected to identify the most significant of these. Gene functional enrichment analyses were performed on these genes, using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes analyses. The protein–protein interaction network of selected genes was analyzed using the Search Tool for the Retrieval of Interacting Genes database. Significantly, differentially expressed genes were further verified with two RNA‐seq datasets (GSE68799 and GSE12452), as well as in clinical samples. Results. In all, 34 (8 upregulated genes and 26 downregulated) genes were identified as significantly differentially expressed. The immune response and the regulation of cell proliferation were the most enriched biological GO terms. Using reverse transcription quantitative real‐time PCR (RT‐qPCR), the genes MMP1, AQP9, and TNFAIP6 were detected to be upregulated, and FAM3D, CR2, and LTF were downregulated in NPC tissue samples. Conclusion. This study provides information on the genes that may be involved in the development of NPC and suggests possible druggable targets and biomarkers for diagnosing and evaluating the prognosis of NPC.Keywords
Funding Information
- National Natural Science Foundation of China (82002885)
This publication has 39 references indexed in Scilit:
- Nasopharyngeal carcinomaThe Lancet, 2016
- Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosisTumor Biology, 2016
- Decreased FOXJ1 expression and its ciliogenesis programme in aggressive ependymoma and choroid plexus tumoursThe Journal of Pathology, 2015
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanismsOncogene, 2012
- Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinomaCancer Letters, 2012
- STAT3 controls matrix metalloproteinase-1 expression in colon carcinoma cells by both direct and AP-1-mediated interaction with the MMP-1 promoterBiological Chemistry, 2011
- High MMP-1 mRNA Expression is a Risk Factor for Disease-Free and Overall Survivals in Patients with Invasive Breast CarcinomaJournal of Surgical Research, 2008
- Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancerBreast Cancer Research, 2007
- COX-2: A Molecular Target for Colorectal Cancer PreventionJournal of Clinical Oncology, 2005